Full Press Release Details
IDEAYA Announces IND Clearance Enabling Phase 1 2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP Deletion Solid Tumors.
IDYA
IDEAYA Announces IND Clearance Enabling Phase 1 2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP Deletion Solid Tumors
Key Takeaway: IDEAYA Announces IND Clearance Enabling Phase 1 2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP Deletion Solid Tumors